[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"metabolic-alcohol-related-liver-disease\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:metabolic-alcohol-related-liver-disease":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":44,"leadSponsor":46,"locationsCount":5},"100627554","a-large-language-model-based-chatbot-for-alcohol-reduction-in-patients-with-metabolic-alcohol-related-liver-disease-100627554",false,"NCT07450144","A Large Language Model-based Chatbot for Alcohol Reduction in Patients With Metabolic Alcohol-Related Liver Disease","A Large Language Model-based Chatbot for Alcohol Reduction Counseling in MetALD Patients: A Pilot Randomized Controlled Trial","Inclusion Criteria:\n\n1\\. Hong Kong residents aged 18 years or above 2. Diagnosed of MASLD:\n\n1. Evidence of hepatic steatosis (fat accumulation in the liver) confirmed by imaging techniques such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), or liver biopsy\n2. Presence of metabolic dysfunction, indicated by at least one of the following:\n\n   * Overweight or obesity (body mass index \\[BMI\\] ≥25 kg\u002Fm²),\n\n     * Type 2 diabetes mellitus, ③Dyslipidemia (elevated triglycerides \\[≥150 mg\u002FdL\\] or low high-density lipoprotein \\[HDL\\] cholesterol \\[\\\u003C40 mg\u002FdL for men, \\\u003C50 mg\u002FdL for women\\]), ④Hypertension (blood pressure ≥130\u002F85 mmHg or use of antihypertensive medication).\n\n       * Metabolic syndrome as defined by established criteria (e.g., International Diabetes Federation \\[IDF\\], Adult Treatment Panel III \\[ATP III\\]) 3. Alcohol consumption: males who drink 210-420 g\u002Fweek (≈263-525 ml), female who drink 140-350 g\u002Fweek (≈175-438 ml) 4. Intention to reduce\u002Fquit alcohol 5. Able to read and communicate in Chinese 6. Own a smartphone with internet access\n\nExclusion Criteria:\n\n1. Diagnosed with mental disease or cognitive impairments, or\n2. Participating in other ongoing clinic trials","ALL","18 Years",{"count":19,"type":20},50,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this pilot randomized controlled trial is to evaluate the trial feasibility and acceptability of LLM-based chatbot for reducing alcohol use among patients with metabolic alcohol-related liver disease. Specific objectives include:\n\n1. To assess how many MetALD patients accept the invitation to participate in the trial\n2. To assess the retention rate of the participants through 3 and 6 months after treatment initiation\n3. To assess the acceptability of the LLM-based chatbot in terms of participants' compliance and usability rating\n4. To estimate the intervention effect on alcohol reduction\n5. To explore the participants' perception and experiences in the chatbot",[26,27],"Metabolic Dysfunction-Associated Steatotic Liver Disease","Metabolic Alcohol-Related Liver Disease",[29,30,31,32,33,34,35,36,37],"drinking","Chinese","mHealth","WhatsApp","BCTs","COM-B model","cirrhosis","Large language model","AI-based chatbot","RECRUITING","2026-03-18",{"date":41,"type":42},"2026-03-23","ACTUAL",{"date":39,"type":20},{"date":45,"type":20},"2027-07-22",{"name":47,"class":48},"The University of Hong Kong","OTHER"]